These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29222609)

  • 1. Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures.
    Lai JS; Goodnight S; Downing NR; Ready RE; Paulsen JS; Kratz AL; Stout JC; McCormack MK; Cella D; Ross C; Russell J; Carlozzi NE
    Qual Life Res; 2018 Mar; 27(3):811-822. PubMed ID: 29222609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.
    Carlozzi NE; Goodnight S; Kratz AL; Stout JC; McCormack MK; Paulsen JS; Boileau NR; Cella D; Ready RE
    J Huntingtons Dis; 2019; 8(4):467-482. PubMed ID: 31424415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcome measures in Huntington disease: Quality of life in neurological disorders (Neuro-QoL) social functioning measures.
    Carlozzi NE; Hahn EA; Goodnight SM; Kratz AL; Paulsen JS; Stout JC; Frank S; Miner JA; Cella D; Gershon RC; Schilling SG; Ready RE
    Psychol Assess; 2018 Apr; 30(4):450-458. PubMed ID: 28557480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD).
    Carlozzi NE; Boileau NR; Roché MW; Ready RE; Perlmutter JS; Chou KL; Barton SK; McCormack MK; Stout JC; Cella D; Miner JA; Paulsen JS
    Qual Life Res; 2020 Dec; 29(12):3419-3439. PubMed ID: 32813263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability and Validity of the HD-PRO-TriadTM, a Health-Related Quality of Life Measure Designed to Assess the Symptom Triad of Huntington's Disease.
    Boileau NR; Stout JC; Paulsen JS; Cella D; McCormack MK; Nance MA; Frank S; Lai JS; Carlozzi NE
    J Huntingtons Dis; 2017; 6(3):201-215. PubMed ID: 28968239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).
    Carlozzi NE; Schilling SG; Lai JS; Paulsen JS; Hahn EA; Perlmutter JS; Ross CA; Downing NR; Kratz AL; McCormack MK; Nance MA; Quaid KA; Stout JC; Gershon RC; Ready RE; Miner JA; Barton SK; Perlman SL; Rao SM; Frank S; Shoulson I; Marin H; Geschwind MD; Dayalu P; Goodnight SM; Cella D
    Qual Life Res; 2016 Oct; 25(10):2441-2455. PubMed ID: 27522213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties and responsiveness of Neuro-QoL Cognitive Function in persons with Huntington disease (HD).
    Carlozzi NE; Boileau NR; Paulsen JS; Downing NR; Ready R; Perlmutter JS; Cella D; Chou KL; McCormack MK; Barton S; Lai JS
    Qual Life Res; 2020 May; 29(5):1393-1403. PubMed ID: 31853881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?
    Carlozzi NE; Schilling S; Kratz AL; Paulsen JS; Frank S; Stout JC
    Qual Life Res; 2018 Oct; 27(10):2541-2555. PubMed ID: 29909483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsiveness to Change Over Time: An Examination of the Neuro-QoL Social Function Measures in Persons with Huntington's Disease.
    Carlozzi NE; Boileau NR; Hahn EA; Barton SK; Cella D; McCormack MK; Ready RE
    J Huntingtons Dis; 2020; 9(1):83-97. PubMed ID: 31744014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDQLIFE and neuro-QoL physical function measures: Responsiveness in persons with huntington's disease.
    Carlozzi NE; Boileau NR; Chou KL; Ready RE; Cella D; McCormack MK; Miner JA; Dayalu P
    Mov Disord; 2020 Feb; 35(2):326-336. PubMed ID: 31724237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in individuals with Huntington disease (HD).
    Carlozzi NE; Kratz AL; Downing NR; Goodnight S; Miner JA; Migliore N; Paulsen JS
    Qual Life Res; 2015 Aug; 24(8):1963-71. PubMed ID: 25636661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes in Huntington's disease: Quality of life in neurological disorders (Neuro-QoL) and Huntington's disease health-related quality of life (HDQLIFE) physical function measures.
    Carlozzi NE; Ready RE; Frank S; Cella D; Hahn EA; Goodnight SM; Schilling SG; Boileau NR; Dayalu P
    Mov Disord; 2017 Jul; 32(7):1096-1102. PubMed ID: 28556412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding speech and swallowing difficulties in individuals with Huntington disease: Validation of the HDQLIFE Speech Difficulties and Swallowing Difficulties Item Banks.
    Carlozzi NE; Boileau NR; Roberts A; Dayalu P; Hanifan DL; Miner JA; Claassen D; Provost EM
    Qual Life Res; 2021 Jan; 30(1):251-265. PubMed ID: 32839864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric evaluation of the pediatric and parent-proxy Patient-Reported Outcomes Measurement Information System and the Neurology and Traumatic Brain Injury Quality of Life measurement item banks in pediatric traumatic brain injury.
    Bertisch H; Rivara FP; Kisala PA; Wang J; Yeates KO; Durbin D; Zonfrillo MR; Bell MJ; Temkin N; Tulsky DS
    Qual Life Res; 2017 Jul; 26(7):1887-1899. PubMed ID: 28271316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties.
    Carlozzi NE; Schilling SG; Lai JS; Perlmutter JS; Nance MA; Waljee JF; Miner JA; Barton SK; Goodnight SM; Dayalu P
    Qual Life Res; 2016 Oct; 25(10):2417-2427. PubMed ID: 27038054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system).
    Carlozzi NE; Downing NR; McCormack MK; Schilling SG; Perlmutter JS; Hahn EA; Lai JS; Frank S; Quaid KA; Paulsen JS; Cella D; Goodnight SM; Miner JA; Nance MA
    Qual Life Res; 2016 Oct; 25(10):2403-2415. PubMed ID: 27393121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the Neurology Quality-of-Life (Neuro-QoL) measurement system in adult epilepsy.
    Victorson D; Cavazos JE; Holmes GL; Reder AT; Wojna V; Nowinski C; Miller D; Buono S; Mueller A; Moy C; Cella D
    Epilepsy Behav; 2014 Feb; 31():77-84. PubMed ID: 24361767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the first quality-of-life measurement for patients with Huntington's disease: the Huntington Quality of Life Instrument.
    Clay E; De Nicola A; Dorey J; Squitieri F; Aballéa S; Martino T; Tedroff J; Zielonka D; Auquier P; Verny C; Toumi M
    Int Clin Psychopharmacol; 2012 Jul; 27(4):208-14. PubMed ID: 22508443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and behavioral changes in Huntington disease before diagnosis.
    Paulsen JS; Miller AC; Hayes T; Shaw E
    Handb Clin Neurol; 2017; 144():69-91. PubMed ID: 28947127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuro-QoL health-related quality of life measurement system: Validation in Parkinson's disease.
    Nowinski CJ; Siderowf A; Simuni T; Wortman C; Moy C; Cella D
    Mov Disord; 2016 May; 31(5):725-33. PubMed ID: 26919664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.